Home068270 • KRX
add
Celltrion Inc
Nakaraang pagsara
₩160,500.00
Sakop ng araw
₩160,200.00 - ₩163,400.00
Sakop ng taon
₩150,400.00 - ₩200,952.39
Market cap
36.28T KRW
Average na Volume
460.25K
P/E ratio
61.82
Dividend yield
0.44%
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 841.91B | 14.24% |
Gastos sa pagpapatakbo | 293.45B | 0.76% |
Net na kita | 108.67B | 384.28% |
Net profit margin | 12.91 | 324.67% |
Kita sa bawat share | 529.00 | 414.31% |
EBITDA | 220.36B | 49.86% |
Aktuwal na % ng binabayarang buwis | 44.58% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 970.72B | 5.45% |
Kabuuang asset | 20.96T | 4.00% |
Kabuuang sagutin | 3.68T | 16.94% |
Kabuuang equity | 17.28T | — |
Natitirang share | 224.61M | — |
Presyo para makapag-book | 2.10 | — |
Return on assets | 1.78% | — |
Return on capital | 1.90% | — |
Cash Flow
Net change in cash
| (KRW) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 108.67B | 384.28% |
Cash mula sa mga operasyon | 113.45B | 206.45% |
Cash mula sa pag-invest | -54.86B | -55.15% |
Cash mula sa financing | -243.49B | -242.88% |
Net change in cash | -167.36B | -191.58% |
Malayang cash flow | 226.51B | 169.09% |
Tungkol
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Itinatag
2002
Website
Mga Empleyado
2,391
